Branched-chain amino acids inhibit the TGF-beta-induced down-regulation of taurine biosynthetic enzyme cysteine dioxygenase in HepG2 cells

• Published in: Amino acids 2014-05, Vol.46 (5), p.1275-1283
• Main Authors: Hagiwara, Asami, Ishizaki, Sonoko, Takehana, Kenji, Fujitani, Shoji, Sonaka, Ichiro, Satsu, Hideo, Shimizu, Makoto
• Format: Article
• Language: English
• Subjects: Amino acids; Amino Acids, Branched-Chain - metabolism; Analytical Chemistry; Animals; Biochemical Engineering; Biochemistry; Biomedical and Life Sciences; Cysteine; Cysteine Dioxygenase - antagonists & inhibitors; Cysteine Dioxygenase - genetics; Cysteine Dioxygenase - metabolism; Cytokines; Diseases; Down-Regulation; Enzymes; Gene expression; Genes; Hep G2 Cells; Humans; Life Sciences; Liver Cirrhosis - enzymology; Liver Cirrhosis - genetics; Liver Cirrhosis - metabolism; Low level; Male; Neurobiology; Original; Original Article; Proteomics; Rats; Rats, Sprague-Dawley; Taurine - biosynthesis; Transforming Growth Factor beta1 - metabolism
• ISSN: 0939-4451; 1438-2199
• DOI: 10.1007/s00726-014-1693-3

Taurine deficiency has been suggested to contribute to the pathogenesis and complications of advanced hepatic diseases. The molecular basis for a low level of taurine associated with hepatic failure is largely unknown. Using carbon tetrachloride (CCl 4 )-induced cirrhotic rat model, we found that the activity and expression of cysteine dioxygenase (CDO), a rate-limiting enzyme in taurine synthesis, were significantly decreased in the liver of these rats. To investigate the underlying mechanisms for the suppression, we examined the effects of pathological cytokines on CDO expression in human hepatoma HepG2 cells. Among the several cytokines, transforming growth factor-β (TGF-β), one of the key mediators of fibrogenesis, suppressed Cdo1 gene transcription through the MEK/ERK pathway. Finally, we further examined potential effects of branched-chain amino acids (BCAA) on CDO expression, as it has been reported that oral BCAA supplementation increased plasma taurine level in the patients with liver cirrhosis. BCAA, especially leucine, promoted Cdo1 gene transcription, and attenuated TGF-β-mediated suppression of Cdo1 gene expression. These results indicate that the low plasma level of taurine in advanced hepatic disease is due to decreased hepatic CDO expression, which can be partly attributed to suppressive effect of TGF-β on Cdo1 gene transcription. Furthermore, our observation that BCAA promotes Cdo1 expression suggests that BCAA may be therapeutically useful to improve hepatic taurine metabolism and further suppress dysfunctions associated with low level of taurine in hepatic diseases.